Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT

Clinical trial NCT01997918 · COMPLETED

Trial details

NCT number: NCT01997918
Sponsor: University Hospital Tuebingen
Status: COMPLETED
Study type: OBSERVATIONAL

Relapse of Hematological Malignancies

Start date: 2013-10-01
Primary completion: 2017-12-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.